MAI Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.9M Sell
70,346
-27,812
-28% -$3.52M 0.06% 254
2025
Q1
$12.6M Buy
98,158
+3,923
+4% +$502K 0.09% 189
2024
Q4
$12.5M Buy
94,235
+4,833
+5% +$639K 0.09% 182
2024
Q3
$13M Sell
89,402
-1,081
-1% -$157K 0.12% 132
2024
Q2
$12.4M Buy
90,483
+33,844
+60% +$4.65M 0.12% 133
2024
Q1
$7.77M Sell
56,639
-924
-2% -$127K 0.08% 196
2023
Q4
$7.82M Sell
57,563
-6,679
-10% -$907K 0.1% 159
2023
Q3
$7.86M Sell
64,242
-1,471
-2% -$180K 0.12% 154
2023
Q2
$8.34M Sell
65,713
-2,171
-3% -$276K 0.12% 148
2023
Q1
$8.77M Buy
67,884
+1,054
+2% +$136K 0.14% 138
2022
Q4
$8.77M Buy
66,830
+2,776
+4% +$364K 0.15% 132
2022
Q3
$7.49M Buy
64,054
+6,535
+11% +$764K 0.14% 138
2022
Q2
$6.77M Buy
57,519
+17,160
+43% +$2.02M 0.13% 133
2022
Q1
$5.26M Sell
40,359
-5,503
-12% -$717K 0.09% 163
2021
Q4
$7M Buy
45,862
+32,221
+236% +$4.92M 0.11% 145
2021
Q3
$2.21M Buy
13,641
+10,511
+336% +$1.7M 0.04% 210
2021
Q2
$512K Buy
3,130
+246
+9% +$40.2K 0.01% 474
2021
Q1
$434K Buy
2,884
+765
+36% +$115K 0.01% 481
2020
Q4
$321K Sell
2,119
-20
-0.9% -$3.03K 0.01% 503
2020
Q3
$290K Buy
2,139
+22
+1% +$2.98K 0.01% 447
2020
Q2
$289K Buy
+2,117
New +$289K 0.01% 431
2018
Q1
Sell
-3,186
Closed -$340K 471
2017
Q4
$340K Buy
3,186
+78
+3% +$8.32K 0.02% 329
2017
Q3
$346K Buy
3,108
+90
+3% +$10K 0.02% 309
2017
Q2
$312K Hold
3,018
0.02% 335
2017
Q1
$295K Sell
3,018
-10,152
-77% -$992K 0.02% 338
2016
Q4
$1.17M Buy
13,170
+3,342
+34% +$296K 0.08% 168
2016
Q3
$948K Buy
9,828
+282
+3% +$27.2K 0.07% 183
2016
Q2
$819K Buy
9,546
+120
+1% +$10.3K 0.06% 204
2016
Q1
$819K Buy
9,426
+930
+11% +$80.8K 0.06% 204
2015
Q4
$958K Buy
8,496
+435
+5% +$49.1K 0.07% 180
2015
Q3
$815K Buy
8,061
+2,907
+56% +$294K 0.06% 217
2015
Q2
$634K Buy
+5,154
New +$634K 0.04% 272